Clinical Trial

Nation-wide Hepatitis C Virus (HCV) Registry in Taiwan

Recruiting
View on ClinicalTrials.gov →
Summary
To determine the treatment efficacy, safety and long-term outcomes of chronic hepatitis C patients receiving directly acting antivirals in Taiwan
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2017-06-26; most recent amendment 2022-04-06.
Trial Details
NCT Number NCT03200379
Lead Sponsor Kaohsiung Medical University Chung-Ho Memorial Hospital
Conditions Hepatitis C, Chronic
Enrollment 150,000 participants
Start Date 2017-06-15
Primary Completion 2037-06-15 (estimated)
Study Completion 2037-06-15 (estimated)
Updated on ClinicalTrials.gov 2022-04-08